The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review

被引：314

作者：

Eskens, Ferry A. L. M. ^{[1
]}

Verweij, Jaap ^{[1
]}

机构：

[1] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands

来源：

EUROPEAN JOURNAL OF CANCER | 2006年 / 42卷 / 18期

关键词：

angiogenesis inhibitors; antibodies; tyrosine kinase inhibitors; VEGF; side-effects; treatment;

D O I：

10.1016/j.ejca.2006.09.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Clinical experience with vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors is rapidly increasing, and some compounds have already been approved for regular anticancer treatment. Apart from their activity, much attention has been focussed on the clinical toxicity profile of these compounds. This review describes the most frequently occurring side-effects of both antibodies and tyrosine kinase inhibitors and discusses some of the underlying mechanisms. Some practical guidelines for treatment of the side-effects are given. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：3127 / 3139

页数：13

共 110 条

[1]

AKLILU M, 2002, P AM SOC CLIN ONCOL

[2]

Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats [J].

Assy, N ;

Spira, G ;

Paizi, M ;

Shenkar, L ;

Kraizer, Y ;

Cohen, T ;

Neufeld, G ;

Dabbah, B ;

Enat, R ;

Baruch, Y .

JOURNAL OF HEPATOLOGY, 1999, 30 (05) :911-915

[3]

Gut mucosal healing: Is the science relevant? [J].

Basson, MD .

AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1101-1105

[4]

BRAHMER J, 2002, P AM SOC CLIN ONCOL

[5]

BRITTEN C, 2002, P AM SOC CLIN ONCOL

[6]

Vascular endothelial growth factor and the nervous system [J].

Brockington, A ;

Lewis, C ;

Wharton, S ;

Shaw, PJ .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (05) :427-446

[7]

Vascular endothelial growth factor (VEGF164) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-β release from epithelial cells [J].

Bulut, K ;

Pennartz, C ;

Felderbauer, P ;

Ansorge, N ;

Banasch, M ;

Schmitz, F ;

Schmidt, WE ;

Hoffmann, P .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (06) :687-692

[8]

Camidge D, 2007, J CLIN ONCOL, V25

[9]

Campos SM, 2007, J CLIN ONCOL, V25

[10]

BAY 43-9006 inhibition of oncogenic RET mutants [J].

Carlomagno, F ;

Anaganti, S ;

Guida, T ;

Salvatore, G ;

Troncone, G ;

Wilhelm, SM ;

Santoro, M .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :326-334

← 1 2 3 4 5 6 7 8 9 10 →